Medicare Enrolled

Dr. Thierry Verstraeten, MD

Ophthalmology · Pittsburgh, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
420 E NORTH AVE STE 116, Pittsburgh, PA 15212
4123596300
In practice since 2006 (20 years)
NPI: 1538120977 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Verstraeten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verstraeten? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Verstraeten

Dr. Thierry Verstraeten is an ophthalmology specialist in Pittsburgh, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Verstraeten performed 10,720 Medicare services across 2,106 unique beneficiaries.

Between the years covered by Open Payments, Dr. Verstraeten received a total of $22,806 from 45 pharmaceutical and/or device companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Verstraeten is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in PA $22,806 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,720
Medicare services
Top 9% in PA for ophthalmology
2,106
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~536 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
6,060 $29 $64
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,447 $28 $89
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
810 $83 $585
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
795 $59 $110
Aflibercept eye injection (Eylea) 627 $688 $1,248
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
452 $55 $97
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
174 $86 $174
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
105 $70 $171
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
82 $98 $190
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $67 $126
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
51 $847 $2,321
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
26 $621 $2,062
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
18 $49 $107
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
16 $859 $2,673
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,806
Total received (2018-2024)
Avg $3,258/year across 7 years
Top 7% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
267
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,408 (63.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,330 (36.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,162
2023
$8,764
2022
$2,754
2021
$660
2020
$511
2019
$6,951
2018
$1,006

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$442
Astellas Pharma US Inc
$357
Alcon Vision LLC
$302
Apellis Pharmaceuticals, Inc.
$247
Harrow Eye, LLC
$228
Genentech USA, Inc.
$186
SUN PHARMACEUTICAL INDUSTRIES INC.
$69
ANI Pharmaceuticals, Inc.
$69
Amgen Inc.
$67
Alimera Sciences, Inc.
$57
ABBVIE INC.
$42
Tarsus Pharmaceuticals, Inc.
$28
Bausch & Lomb Americas Inc.
$28
Rayner Intraocular Lenses Limited
$20
Dutch Ophthalmic, USA
$18
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$8,416
Dutch Ophthalmic, USA
$3,954
Regeneron Healthcare Solutions, Inc.
$2,029
Bausch & Lomb Americas Inc.
$1,735
ThromboGenics, Inc.
$1,505
Alcon Vision LLC
$631
Astellas Pharma US Inc
$624
Apellis Pharmaceuticals, Inc.
$580
Novartis Pharmaceuticals Corporation
$383
Harrow Eye, LLC
$250
Allergan Inc.
$210
Ivantis, Inc
$206
Bausch & Lomb, a division of Bausch Health US, LLC
$195
Halozyme Inc
$159
Biogen, Inc.
$158
Mallinckrodt Enterprises LLC
$150
Genentech, Inc.
$138
Regeneron Pharmaceuticals, Inc.
$125
Sun Pharmaceutical Industries Inc.
$122
Alimera Sciences, Inc.
$109
Spark Therapeutics, Inc.
$104
ABBVIE INC.
$95
NEW WORLD MEDICAL,INC.
$89
AbbVie Inc.
$77
Aerie Pharmaceuticals, Inc.
$70
SUN PHARMACEUTICAL INDUSTRIES INC.
$69
ANI Pharmaceuticals, Inc.
$69
Notal Vision, Inc.
$69
Amgen Inc.
$67
Alcon Laboratories Inc
$64
OPTOVUE, INC.
$58
Allergan, Inc.
$30
Eyevance Pharmaceuticals LLC
$29
Tarsus Pharmaceuticals, Inc.
$28
Mallinckrodt LLC
$27
Beaver-Visitec International, Inc.
$23
Shire North American Group Inc
$22
Horizon Therapeutics plc
$21
Vyera Pharmaceuticals, LLC
$21
Rayner Intraocular Lenses Limited
$20
EyePoint Pharmaceuticals US, Inc.
$17
Omeros Corporation
$15
Akorn, Inc.
$15
TissueTech, Inc.
$15
NovaBay Pharmaceuticals, Inc.
$13
Top 3 companies account for 63.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · AcrySof · Ahmed Glaucoma Valve · Avenova · BEOVU · BROMSITE · CEQUA · COMBIGAN · Cequa · DEXYCU · DUREZOL · DURYSTA · Daraprim 30 Tablet in 1 Bottle · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · HYLENEX RECOMBINANT · Hydrus · Hylenex · IHEEZO · ILEVRO · ILUVIEN · Iluvien · Izervay · Jetrea · Kahook Dual Blade · LUXTURNA · Lucentis · Luxor · NGENUITY · OZURDEX · Omidria · PROLENSA · PURIFIED CORTROPHIN GEL · Prokera · Rhopressa · Rocklatan · STELLARIS PC · SUSVIMO · Stellaris · Syfovre · TEPEZZA · VABYSMO · VEVYE · VITESSE · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · XR · YUTIQ · ZYLET · Zioptan · combined machine · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for ophthalmology in PA.

Looking for an ophthalmology specialist in Pittsburgh?
Compare ophthalmologists in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
187
Per 100K population
15.1
County median income
$76,393
Nearest hospital
ALLEGHENY GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Verstraeten is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with consulting-driven industry engagement in the top 7% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Verstraeten experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Verstraeten performed 6,060 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verstraeten receive payments from pharmaceutical companies?
Yes. Dr. Verstraeten received a total of $22,806 from 45 companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verstraeten's costs compare to other ophthalmologists in Pittsburgh?
Dr. Verstraeten's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verstraeten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →